Inno-Gene Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Inno-Gene.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Life Sciences earnings growth26.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Here's Why We Think Inno-Gene (WSE:IGN) Might Deserve Your Attention Today

Jul 25
Here's Why We Think Inno-Gene (WSE:IGN) Might Deserve Your Attention Today

Here's Why We Think Inno-Gene (WSE:IGN) Is Well Worth Watching

Apr 05
Here's Why We Think Inno-Gene (WSE:IGN) Is Well Worth Watching

Here's Why I Think Inno-Gene (WSE:IGN) Is An Interesting Stock

Dec 28
Here's Why I Think Inno-Gene (WSE:IGN) Is An Interesting Stock

Should You Be Adding Inno-Gene (WSE:IGN) To Your Watchlist Today?

Aug 28
Should You Be Adding Inno-Gene (WSE:IGN) To Your Watchlist Today?

We Wouldn't Rely On Inno-Gene's (WSE:IGN) Statutory Earnings As A Guide

Feb 17
We Wouldn't Rely On Inno-Gene's (WSE:IGN) Statutory Earnings As A Guide

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Inno-Gene has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

WSE:IGN - Analysts future estimates and past financials data (PLN Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20240-6-1-1N/A
3/31/20240-1-1-1N/A
12/31/20231-6-3-3N/A
9/30/20232-2-4-4N/A
6/30/20233-2-5-5N/A
3/31/2023-9-6-6-6N/A
12/31/202216000N/A
9/30/202224033N/A
6/30/202233388N/A
3/31/202239101010N/A
12/31/202130677N/A
9/30/202123655N/A
6/30/202115522N/A
3/31/202161-1-1N/A
12/31/20205000N/A
9/30/20203101N/A
6/30/20202011N/A
3/31/20201001N/A
12/31/20191001N/A
9/30/20191-103N/A
6/30/201921-12N/A
3/31/20193103N/A
12/31/201830-12N/A
9/30/201831-1-1N/A
6/30/20183100N/A
3/31/201831N/A0N/A
12/31/201731N/A-1N/A
9/30/201740N/A2N/A
6/30/20174-1N/A0N/A
3/31/20174-2N/A0N/A
12/31/20165-3N/A-1N/A
9/30/20165-3N/A6N/A
6/30/20164-3N/A8N/A
3/31/20165-1N/A7N/A
12/31/20154-1N/A9N/A
9/30/201541N/A1N/A
6/30/201542N/A2N/A
3/31/201542N/A1N/A
12/31/201442N/A2N/A
9/30/201440N/A-1N/A
6/30/20144-1N/A-1N/A
3/31/20143-1N/AN/AN/A
12/31/201330N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if IGN's forecast earnings growth is above the savings rate (4.1%).

Earnings vs Market: Insufficient data to determine if IGN's earnings are forecast to grow faster than the Polish market

High Growth Earnings: Insufficient data to determine if IGN's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if IGN's revenue is forecast to grow faster than the Polish market.

High Growth Revenue: Insufficient data to determine if IGN's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if IGN's Return on Equity is forecast to be high in 3 years time


Discover growth companies